Browse > Article
http://dx.doi.org/10.3345/kjp.2013.56.8.327

Lower fat and better quality diet therapy for children with pharmacoresistant epilepsy  

Yoon, Jung-Rim (Division of Pediatric Neurology, Department of Pediatrics, Pediatric Epilepsy Clinic, Epilepsy Research Institute, Severance Children's Hospital, Yonsei University College of Medicine)
Kim, Heung Dong (Division of Pediatric Neurology, Department of Pediatrics, Pediatric Epilepsy Clinic, Epilepsy Research Institute, Severance Children's Hospital, Yonsei University College of Medicine)
Kang, Hoon-Chul (Division of Pediatric Neurology, Department of Pediatrics, Pediatric Epilepsy Clinic, Epilepsy Research Institute, Severance Children's Hospital, Yonsei University College of Medicine)
Publication Information
Clinical and Experimental Pediatrics / v.56, no.8, 2013 , pp. 327-331 More about this Journal
Abstract
The ketogenic diet (KD) is an established, effective, nonpharmacologic treatment for children with pharmacoresistant epilepsy. Although the KD is the most well-established dietary therapy for epilepsy, it is too restrictive and is associated with serious complications; therefore, alternative lower-fat diets, including a modified Atkins diet and low-glycemic index diet, have been developed. Recent ongoing clinical evidence suggests that other dietary therapies have an efficacy almost comparable to that of the KD. In addition, a diet rich in polyunsaturated fatty acids appears to increase the efficacy of diet therapy and reduce the complications of a high-fat diet. Here, we review the systematic information about lower-fat diets and better-quality dietary therapies and the current clinical status of each of these dietary approaches.
Keywords
Ketogenic diet; Atkins diet; Low-glycemic index diet; Polyunsaturated fatty acid; Epilepsy;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Yehuda S, Carasso RL, Mostofsky DI. Essential fatty acid preparation (SR-3) raises the seizure threshold in rats. Eur J Pharmacol 1994; 254:193-8.   DOI
2 Bough KJ, Rho JM. Anticonvulsant mechanisms of the ketogenic diet. Epilepsia 2007;48:43-58.
3 Fraser DD, Whiting S, Andrew RD, Macdonald EA, Musa-Veloso K, Cunnane SC. Elevated polyunsaturated fatty acids in blood serum obtained from children on the ketogenic diet. Neurology 2003;60:1026-9.   DOI
4 Lavie CJ, Milani RV, Mehra MR, Ventura HO. Omega-3 polyunsaturated fatty acids and cardiovascular diseases. J Am Coll Cardiol 2009;54:585-94.   DOI
5 Geyelin HR. Fasting as a method for treating epilepsy. Med Rec 1921;99:1037-9.
6 Huttenlocher PR, Wilbourn AJ, Signore JM. Medium-chain triglycerides as a therapy for intractable childhood epilepsy. Neurology 1971;21:1097-103.   DOI
7 Kossoff EH, McGrogan JR. Worldwide use of the ketogenic diet. Epilepsia 2005;46:280-9.
8 Kossoff EH. More fat and fewer seizures: dietary therapies for epilepsy. Lancet Neurol 2004;3:415-20.   DOI
9 Swink TD, Vining EP, Freeman JM. The ketogenic diet: 1997. Adv Pediatr 1997;44:297-329.
10 Schwartz RH, Eaton J, Bower BD, Aynsley-Green A. Ketogenic diets in the treatment of epilepsy: short-term clinical effects. Dev Med Child Neurol 1989;31:145-51.
11 Thiele EA. Assessing the efficacy of antiepileptic treatments: the ketogenic diet. Epilepsia 2003;44 Suppl 7:26-9.   DOI
12 Kang HC, Kim YJ, Kim DW, Kim HD. Efficacy and safety of the ketogenic diet for intractable childhood epilepsy: Korean multicentric experience. Epilepsia 2005;46:272-9.   DOI
13 Miranda MJ, Turner Z, Magrath G. Alternative diets to the classical ketogenic diet: can we be more liberal? Epilepsy Res 2012;100:278-85.   DOI
14 Cross JH, Neal EG. The ketogenic diet: update on recent clinical trials. Epilepsia 2008;49 Suppl 8:6-10.   DOI
15 Hemingway C, Freeman JM, Pillas DJ, Pyzik PL. The ketogenic diet: a 3- to 6-year follow-up of 150 children enrolled prospectively. Pediatrics 2001;108:898-905.   DOI
16 Kang HC, Chung DE, Kim DW, Kim HD. Early- and late-onset complications of the ketogenic diet for intractable epilepsy. Epilepsia 2004;45:1116-23.   DOI
17 Kossoff EH, McGrogan JR, Bluml RM, Pillas DJ, Rubenstein JE, Vining EP. A modified Atkins diet is effective for the treatment of intractable pediatric epilepsy. Epilepsia 2006;47:421-4.   DOI
18 Miranda MJ, Mortensen M, Povlsen JH, Nielsen H, Beniczky S. Danish study of a modified Atkins diet for medically intractable epilepsy in children: can we achieve the same results as with the classical ketogenic diet? Seizure 2011;20:151-5.   DOI
19 Kim YM, Vaidya VV, Khusainov T, Kim HD, Kim SH, Lee EJ, et al. Various indications for a modified Atkins diet in intractable childhood epilepsy. Brain Dev 2012;34:570-5.   DOI
20 Porta N, Vallee L, Boutry E, Fontaine M, Dessein AF, Joriot S, et al. Comparison of seizure reduction and serum fatty acid levels after receiving the ketogenic and modified Atkins diet. Seizure 2009;18: 359-64.   DOI
21 Tonekaboni SH, Mostaghimi P, Mirmiran P, Abbaskhanian A, Abdollah Gorji F, Ghofrani M, et al. Efficacy of the Atkins diet as therapy for intractable epilepsy in children. Arch Iran Med 2010;13: 492-7.
22 Weber S, Molgaard C, Karentaudorf, Uldall P. Modified Atkins diet to children and adolescents with medical intractable epilepsy. Seizure 2009;18:237-40.   DOI
23 Kang HC, Lee HS, You SJ, Kang du C, Ko TS, Kim HD. Use of a modified Atkins diet in intractable childhood epilepsy. Epilepsia 2007;48:182-6.
24 Pfeifer HH, Thiele EA. Low-glycemic-index treatment: a liberalized ketogenic diet for treatment of intractable epilepsy. Neurology 2005;65:1810-2.   DOI
25 Muzykewicz DA, Lyczkowski DA, Memon N, Conant KD, Pfeifer HH, Thiele EA. Efficacy, safety, and tolerability of the low glycemic index treatment in pediatric epilepsy. Epilepsia 2009;50:1118-26.   DOI
26 Dahlin M, Hjelte L, Nilsson S, Amark P. Plasma phospholipid fatty acids are influenced by a ketogenic diet enriched with n-3 fatty acids in children with epilepsy. Epilepsy Res 2007;73:199-207.   DOI
27 Taha AY, Burnham WM, Auvin S. Polyunsaturated fatty acids and epilepsy. Epilepsia 2010;51:1348-58.   DOI